Ghochikyan, AnahitVasilevko, VitalyPetrushina, IrinaMovesesyan, NinaBabikyan, DavitTian, WenqiangSadzikava, NadyaRoss, Ted M.Head, ElizabethCribbs, David H.Agadjanyan, MIchael G.2011-04-292011-05-172011-04-292011-05-172003-12European Journal of Immunology; 33:12 p. 3232-3241http://hdl.handle.net/10342/3443Active immunization with fibrillar beta-amyloid peptide (AB42) as well as passive transfer of anti-AB antibodies significantly reduces AB plaque deposition, neuritic dystrophy, and astrogliosis in the brain of mutant amyloid precursor protein (APP)-transgenic mice. Although the mechanism(s) of clearance of AB from the brain following active or passive immunization remains to be determined, it is clear that anti-AB antibodies are critical for clearance. DNA immunization provides an attractive alternative to direct peptide and adjuvant approaches for inducing a humoral response to AB. We constructed a DNA minigene with AB fused to mouse interleukin-4 (pAB42-IL-4) as a molecular adjuvant to generate anti-AB antibodies and enhance the Th2-type of immune responses. Gene gun immunizations induced primarily IgG1 and IgG2b anti-AB antibodies. Fine epitope analysis with overlapping peptides of the AB42 sequence identified the 1- 15 region as a dominant B cell epitope. The DNA minigeneinduced anti-AB antibodies bound to AB plaques in brain tissue from an Alzheimer's disease patient demonstrating functional activity of the antibodies and the potential for therapeutic efficacy. Originally published European Journal of Immunology, Vol. 33, No. 12, Dec 2003en-USAuthor notified of opt-out rights by Cammie Jennings prior to upload of this article.DNA immunizationAntibodiesEpitopesMiceAntigensArticlePMC152485710.1002/eji.200324000